血管内超声对下肢外周动脉疾病血管内介入治疗的中期效果:系统评价与Meta分析
该系统评价与Meta分析检索MEDLINE和EMBASE至2023年4月,纳入1项随机对照试验和14项观察性研究,共708,808例患者、709,189处病变,比较IVUS引导与单纯造影引导的血管内治疗。IVUS引导与再狭窄/闭塞风险呈非显著下降趋势(RR 0.74,95%CI 0.54-1.00,I²=60%),大截肢风险显著降低(RR 0.74,95%CI 0.67-0.82,I²=47%),靶病变血运重建和死亡率相当。
要点
- IVUS引导EVT与再狭窄/闭塞风险呈非显著下降趋势(RR 0.74,95%CI 0.54-1.00,I²=60%)。
- IVUS引导EVT与大截肢风险显著降低相关(RR 0.74,95%CI 0.67-0.82,I²=47%)。
- 靶病变血运重建(RR 0.85,95%CI 0.65-1.10,I²=70%)和死亡率(RR 1.01,95%CI 0.79-1.28,I²=43%)两组相当。
核心结论
- 对于PAD患者,与单纯造影引导EVT相比,IVUS引导EVT可能与较低的大截肢率相关,但通畅性差异仍为有利于IVUS引导EVT的非显著趋势。
- 作者认为EVT期间辅助使用IVUS可能有益,并指出需要进一步的前瞻性研究来阐明这一关系及该技术在常规实践中的适用性。
研究设计与样本
- 系统评价与Meta分析,检索MEDLINE和EMBASE至2023年4月,纳入比较IVUS联合造影引导EVT与单纯造影引导EVT的研究。
- 共纳入1项随机对照试验和14项观察性研究,质量大多为中等,合计708,808例患者、709,189处病变。
- IVUS引导EVT组n=101,405,单纯造影引导组n=607,784。
主要发现
- 与单纯造影相比,IVUS引导EVT与再狭窄/闭塞风险呈非显著下降趋势相关(RR 0.74,95%CI 0.54-1.00,I²=60%)。
- 靶病变血运重建风险两组相当(RR 0.85,95%CI 0.65-1.10,I²=70%)。
- 死亡率两组相当(RR 1.01,95%CI 0.79-1.28,I²=43%)。
- IVUS使用与大截肢风险显著降低相关(RR 0.74,95%CI 0.67-0.82,I²=47%)。
- 针对股腘动脉病变的亚组分析显示通畅性显著更高(RR 0.72,95%CI 0.52-0.98,I²=73%),但未观察到大截肢方面的优势。
临床怎么用
- 作者认为EVT期间辅助使用IVUS可能有益,并指出需要进一步的前瞻性研究来阐明这一关系及该技术在常规实践中的适用性。
局限性
- 纳入研究大多为中等质量。
- 再狭窄/闭塞分析存在异质性(I²=60%)。
- 靶病变血运重建分析存在异质性(I²=70%)。
- 死亡率分析存在异质性(I²=43%)。
- 大截肢分析存在异质性(I²=47%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Intravascular ultrasound (IVUS) is an important adjunctive tool for patients with lower extremity peripheral arterial disease (PAD) undergoing endovascular therapy (EVT). The evidence regarding the advantages of IVUS use is evolving, and recent studies have reported conflicting results. We aimed to perform a meta-analysis to evaluate the efficacy of IVUS during angiography-guided EVT for patients with PAD. METHODS: MEDLINE and EMBASE were searched through April 2023 to identify studies that investigated the outcomes of IVUS with angiography-guided EVT vs angiography-alone-guided EVT. The primary outcome was restenosis/occlusion rate; secondary outcomes were target lesion revascularization, major amputation, and mortality. RESULTS: One randomized controlled trial and 14 observational studies, largely of moderate quality, were included, yielding a total of 708,808 patients with 709,189 lesions that were treated with IVUS-guided EVT (n = 101,405) vs angiography-alone (n = 607,784). Compared with angiography alone, IVUS-guided EVT was associated with a non-significant trend towards decreased restenosis/occlusion (relative risk [RR], 0.74; 95% confidence interval [CI], 0.54-1.00; I2 = 60%). Although the risk of target lesion revascularization and mortality were comparable (RR, 0.85; 95% CI, 0.65-1.10; I2 = 70%; RR, 1.01; 95% CI, 0.79-1.28; I2 = 43%, respectively), the use of IVUS was also associated with significantly lower risk of major amputation (RR, 0.74; 95% CI, 0.67-0.82; I2 = 47%). Subgroup analysis focusing on femoropopliteal disease demonstrated significantly higher patency (RR, 0.72; 95% CI, 0.52-0.98; I2 = 73%). However, superiority with major amputation was not observed. CONCLUSIONS: IVUS-guided EVT for PAD may possibly be associated with a lower major amputation rate compared with angiography alone-guided EVT, although the difference in patency remained an insignificant trend in favor of IVUS-guided EVT. Adjunctive use of IVUS during EVT may be beneficial, and further prospective studies are warranted to delineate this relationship and the applicability of this technology in routine practice.
引用
- Tsukagoshi J, Shimoda T, Yokoyama Y, et al. The mid-term effect of intravascular ultrasound on endovascular interventions for lower extremity peripheral arterial disease: A systematic review and meta-analysis. J Vasc Surg. 2023. PMID: 37678642. doi:10.1016/j.jvs.2023.08.128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。